Drug intelligence / Profile preview

jianaikang concentrated pill

Development stage
Unknown
Lead developer
First Affiliated Hospital of Henan University of Chinese Medicine
Administration
Oral
01

Overview

Jianaikang concentrated pill is a Traditional Chinese Medicine (TCM) formulation developed by the First Affiliated Hospital of Henan University of Chinese Medicine for the treatment of HIV infection. It is typically administered as part of a multi-component TCM regimen, which may include Yiaikang capsules and Tangcao tablets, aimed at delaying the progression of HIV to AIDS and improving the quality of life for patients on stable highly active antiretroviral therapy (HAART). The formulation is designed to stabilize CD4+ T-lymphocyte counts and modulate the immune response through its herbal constituents. As a concentrated pill (nongsuowan), it represents a modern TCM dosage form where herbal decoctions are concentrated and processed into small, dense pills for improved stability and patient compliance.

Brand names
Jianaikang
Other names
Jian Ai KangJianaikang Nongsuowan健艾康浓缩丸

Beyond the preview

Go deeper on jianaikang concentrated pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on jianaikang concentrated pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call